Health News

Some Lack Access to Hypertension Rx
African Americans face a higher risk of hypertension, or high blood pressure. Unfortunately, they aren't as likely as others to be prescribed the best medicine to treat the condition.
New Life For Advanced Cancer Patients
Gemzar (gemcitabine) is the standard of care for pancreatic cancer. Results from a trial showed that adding another medication worked even better.
Does Rinse and Repeat Apply To CT Scans?
Patients want the best care, especially when it comes to potential brain injury. Is more scanning always the best option or is it best to wait for evidence that imaging is needed?
Blood Pressure and Brain Damage
Controlling blood pressure is important for heart health. A recent study suggested it may also be important for brain heath.
Why Stressors Make Us Eat
What is it about stress that makes denser foods more appealing? In the modern world, the survival instinct can trigger the now unnecessary desire to eat high-calorie foods. 
Children With Leukemia Have New Rx
Acute lymphoblastic leukemia (ALL) is the most common blood cancer found in children. It’s diagnosed in nearly 3,000 children in the United States every year and can progress quickly if left untreated. These kids now have a new treatment option.
FDA Approves Gleevec for Children With Acute Lymphoblastic Leukemia
The US Food and Drug Administration today approved a new use of Gleevec ( imatinib ) to treat children newly diagnosed with Philadelphia chromosome positive ( Ph +) acute lymphoblastic leukemia (ALL).
FDA Approves Exjade for Genetic Blood Disorder
The US Food and Drug Administration today expanded the approved use of Exjade (deferasirox) to treat patients ages 10 years and older who have chronic iron overload resulting from a genetic blood disorder called non-transfusion-dependent thalassemia (NTDT).
Cancer Trends Nobody’s Talking About
The cancer statistical bibles have been released this year. The American Cancer Society focused on the outstanding news – that cancer deaths declined 20 percent between 1991 and 2009. What wasn’t mentioned is the rising number of different types of cancers and increasing numbers of deaths estimated for this year – 2013.
Tolvaptan has Liver Injury Risk Says FDA
Otsuka and FDA notified healthcare professionals of significant liver injury associated with the use of Samsca.
<< first846847848849850851852853854last >>

REFINE